Comments on: Cubist Enrolls First Patient in Phase 3 Efficacy Studies Evaluating Bevenopran for the Treatment of Opioid-Induced Constipation

Comments on: Cubist Enrolls First Patient in Phase 3 Efficacy Studies Evaluating Bevenopran for the Treatment of Opioid-Induced Constipation https://www.worldpharmatoday.com/press-releases/cubist-enrolls-first-patient-in-phase-3-efficacy-studies-evaluating-bevenopran-for-the-treatment-of-opioid-induced-constipation/ Magazine for the C-level Pharma Executives Wed, 17 Jul 2013 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4